Departmentof Oncology and Human Genetics, Research Institute of the McGill University Health Centre, and the Lady Davis Institute of the Jewish General Hospital, McGill University, Montreal, QC H2W 1S6, Canada.
N Engl J Med. 2010 Nov 11;363(20):1938-48. doi: 10.1056/NEJMra1001389.
Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.
三阴性乳腺癌，之所以这样命名是因为它缺乏雌激素受体、孕激素受体和 HER2 的表达，通常是基底样乳腺癌，但也并非总是如此。这篇综述重点介绍了它的起源、分子和临床特征以及治疗。
